2-(Alkyl/Aryl)Amino-6-Benzylpyrimidin-4(3<i>H</i>)-ones as Inhibitors of Wild-Type and Mutant HIV-1: Enantioselectivity Studies
Dante Rotili(Sapienza University of Rome), Antonello Mai(Sapienza University of Rome), Alberta Samuele(Istituto di Genetica Molecolare), Roberto Cirilli(Istituto Superiore di Sanità), Marco Pierini(Istituto Pasteur), Ludovica Morera(Istituto Pasteur), Bonaventura Clotet(IrsiCaixa), Ira Musmuca(Istituto Pasteur), Marino Artico(University of Salerno), José A. Esté(Universitat Autònoma de Barcelona), Giovanni Maga(National Research Council), Emmanuel González(Inserm), Domenico Tarantino(Istituto Pasteur), Giorgia Botta(Istituto Pasteur), Rino Ragno(Istituto Pasteur), Maxim B. Nawrozkij(Volgograd State Technical University), Flavio Ballante(Uppsala University)
Cited by 31
Related Papers
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
|Journal of Cell Science|2003|1.1k
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase: Synthesis, Biological Evaluation, and Molecular Modeling
|Journal of Medicinal Chemistry|1998|162